Magpale, Nicasio R.
HRN: 22-61-27 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/05/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
12/05/2025
12/12/2025
IV
2.25g
Q6h
CAP-MR; NONHEALING WOUND, LEFT
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: No Wrong Dose
Final appropriateness: Yes
Overall appropriateness: Yes